4//SEC Filing
Friberg Gregory R 4
Accession 0001048477-24-000146
CIK 0001048477other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:51 PM ET
Size
8.3 KB
Accession
0001048477-24-000146
Insider Transaction Report
Form 4
Friberg Gregory R
EVP, Chief R&D Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2024-09-30+49,850→ 49,850 totalExercise: $70.29From: 2025-09-30Exp: 2034-09-29→ Common Stock (49,850 underlying) - Award
Common Stock
2024-09-30+21,190→ 21,190 total - Award
Common Stock
2024-09-30+7,870→ 29,060 total
Footnotes (2)
- [F1]Restricted stock units granted on September 30, 2024. Price not applicable.
- [F2]Option grant vests 12/48th on September 30, 2025 and 1/48th per month thereafter.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0002038768
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:51 PM ET
- Size
- 8.3 KB